Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid plus corticosteroid versus corticosteroid alone for tibiofemoral knee osteoarthritis
ChiCTR1900027519Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hyaluronic acid and lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: WOMAC pain subscale score at 24 weeks. Started Nov 2019; status: recruiting.
02
Drugs
hyaluronic acidlidocaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900027519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027519.